Autonomix Medical, Inc. (AMIX)
NASDAQ: AMIX · Real-Time Price · USD
2.360
-0.020 (-0.84%)
Mar 4, 2025, 11:22 AM EST - Market open

Autonomix Medical Cash Flow Statement

Millions USD. Fiscal year is Apr - Mar.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022
Period Ending
Dec '24 Mar '24 Mar '23 Mar '22
Net Income
-13.63-15.43-1.99-13.33
Depreciation & Amortization
0.180.08--
Other Amortization
---0.05
Stock-Based Compensation
1.480.62-13.17
Other Operating Activities
3.138--0.48
Change in Accounts Payable
-0.430.320.080.09
Change in Other Net Operating Assets
1.24-0.240.060.12
Operating Cash Flow
-8.04-6.65-1.85-0.39
Capital Expenditures
-0.01-0.02--
Investing Cash Flow
-0.01-0.02--
Short-Term Debt Issued
---0.4
Long-Term Debt Issued
-2-0.14
Total Debt Issued
-2-0.54
Net Debt Issued (Repaid)
-2-0.54
Issuance of Common Stock
20.8913.710.682
Other Financing Activities
-2.24-1.3--0.11
Financing Cash Flow
18.6514.410.682.43
Net Cash Flow
10.617.74-1.182.04
Free Cash Flow
-8.05-6.67-1.85-0.39
Free Cash Flow Per Share
-7.59-9.12-3.08-3.74
Levered Free Cash Flow
-4.69-4.27-1.11-
Unlevered Free Cash Flow
-4.58-4.22-1.11-
Change in Net Working Capital
-0.50.23-0.14-
Source: S&P Capital IQ. Standard template. Financial Sources.